Aarti Pharmalabs (BOM:543748) Treasury Stock: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543748 Aarti Pharmalabs Ltd BOM:543748
55 GF Score
Price ₹821.45
GF Value ₹687.37
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Aarti Pharmalabs Treasury Stock?

Aarti Pharmalabs BOM:543748 +20.00% 55 Treasury Stock is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:543748 with a GF Score™ of 55/100 and a GF Value™ of ₹687.37 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Treasury stock is the portion of shares that a company keeps in their own treasury. Aarti Pharmalabs's treasury stock for the quarter that ended in Jun. 2026 was ₹0 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Aarti Pharmalabs Treasury Stock Historical Data

* Premium members only.

The historical data trend for Aarti Pharmalabs's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aarti Pharmalabs Treasury Stock Chart

Aarti Pharmalabs Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Treasury Stock
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Aarti Pharmalabs Quarterly Data
Mar21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:543748
55GF Score
Aarti Pharmalabs Ltd BOM:543748
Treasury Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aarti Pharmalabs Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of ₹0 Mil mean?
Aarti Pharmalabs (BOM:543748) has a Treasury Stock of ₹0 Mil as of Jun. 2026. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Aarti Pharmalabs and its competitors.
Is Aarti Pharmalabs' Treasury Stock too high?
Aarti Pharmalabs' current Treasury Stock is ₹0 Mil. Overall, Aarti Pharmalabs has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aarti Pharmalabs' Treasury Stock compare to ZTS?
Aarti Pharmalabs' Treasury Stock of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Drug Manufacturers company?
A good Treasury Stock depends on the Drug Manufacturers industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Aarti Pharmalabs and its competitors. Aarti Pharmalabs's current Treasury Stock is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aarti Pharmalabs stock overvalued right now?
Based on GuruFocus' analysis, Aarti Pharmalabs (BOM:543748) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹687.37, compared to a current price of ₹821.45 — trading 19.5% above its estimated fair value. The current Treasury Stock is ₹0 Mil. Aarti Pharmalabs' overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For Aarti Pharmalabs (BOM:543748), the current Treasury Stock is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aarti Pharmalabs (BOM:543748) Overvalued in 2026?

Based on GuruFocus' analysis, Aarti Pharmalabs stock appears to be overvalued. The current stock price of ₹821.45 is trading 19.5% above its estimated GF Value™ of ₹687.37. GuruFocus considers Aarti Pharmalabs to be Modestly Overvalued.

Key valuation signals for BOM:543748:

  • Treasury Stock: ₹0 Mil
  • GF Value™: ₹687.37 vs. price of ₹821.45 (19.5% above fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the BOM:543748 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aarti Pharmalabs Business Description

Other Exchanges AARTIPHARM:India
Address Mulund Goregaon Link Road, 204, 2nd Floor, Udyog Kshetra, Mulund West, Mumbai, MH, IND, 400080
Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. The company manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, acids, and xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline in India. It also offers Contract Development and Manufacturing Services (CDMS) for drug substance (NCE, RSM, Intermediates) projects. Geographically, the company generates maximum revenue from its customers located outside India.
55GF Score

Get the complete analysis for BOM:543748

Treasury Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹821.45
Price
₹687.37
GF Value